• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苏州慢性阻塞性肺疾病的流行病学及危险因素:一项基于人群的横断面研究。

Epidemiology and risk factors of chronic obstructive pulmonary disease in Suzhou: a population-based cross-sectional study.

作者信息

Yan Xiaopei, Xu Li, Shi Baoyu, Wang Hui, Xu Xiao, Xu Guopeng

机构信息

Department of Pulmonary and Critical Care Medicine, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, China.

出版信息

J Thorac Dis. 2020 Oct;12(10):5347-5356. doi: 10.21037/jtd-20-1616.

DOI:10.21037/jtd-20-1616
PMID:33209368
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7656423/
Abstract

BACKGROUND

The prevalence of chronic obstructive pulmonary disease (COPD) in Suzhou remains still unknown. The aim of this study was to quantify the disease burden and assess the risk factors of COPD.

METHODS

This was a population-based, cross-sectional study of adults aged 40 years and older in Suzhou. A total of 4,864 adults were identified from June 2018 to December 2018 and 4,725 adults were finally recruited. Subjects underwent post-bronchodilator spirometry and were diagnosed according to the 2018 Global Initiative for Chronic Obstructive Lung Disease (GOLD).

RESULTS

The data from 4,725 adults were ultimately included in the final analysis. The overall prevalence of COPD in subjects aged 40 and older was 12.4%, while it was 12.3% in men and 12.5% in women. Risk factors identified by multivariable logistic analysis were age (P<0.05, OR =2.29, 95% CI, 1.83-2.88) and underweight (BMI <18.5 kg/m) (P<0.05, OR =1.57, 95% CI, 1.01-2.44). COPD patients also displayed weaker grip strength (P<0.001). Approximately half (50.7%) the COPD patients were asymptomatic, and compared with asymptomatic COPD patients, symptomatic COPD patients were older (69.5 67.2, P<0.05), smoked more frequently (12.1 7.1 pack year, P<0.05), had a more severe GOLD stage (stage I 27.0% 39.4%, stage II 50.2% 46.8%, stage III 17.0% 11.1%, stage IV 5.8% 2.7%, P<0.05), and a worse lung function index (FEV, FVC, PEF, FEF, FEF, FEF, FEF) (P<0.05).

CONCLUSIONS

COPD was found to be highly prevalent in adults aged 40 years and older in Suzhou. Age and underweight were major risk factors of COPD. Half of the COPD patients were asymptomatic, and displayed decreased lung function upon the onset of respiratory symptoms. Therefore, spirometry screening is essential for the early detection and management of COPD.

摘要

背景

苏州慢性阻塞性肺疾病(COPD)的患病率仍不清楚。本研究旨在量化疾病负担并评估COPD的危险因素。

方法

这是一项基于人群的苏州40岁及以上成年人的横断面研究。2018年6月至2018年12月共确定了4864名成年人,最终招募了4725名成年人。受试者接受支气管扩张剂后肺量计检查,并根据2018年慢性阻塞性肺疾病全球倡议(GOLD)进行诊断。

结果

最终将4725名成年人的数据纳入最终分析。40岁及以上受试者中COPD的总体患病率为12.4%,男性为12.3%,女性为12.5%。多变量逻辑分析确定的危险因素为年龄(P<0.05,OR=2.29,95%CI,1.83-2.88)和体重过轻(BMI<18.5kg/m)(P<0.05,OR=1.57,95%CI,1.01-2.44)。COPD患者的握力也较弱(P<0.001)。约一半(50.7%)的COPD患者无症状,与无症状COPD患者相比,有症状的COPD患者年龄更大(69.5对67.2,P<0.05),吸烟更频繁(12.1对7.1包年,P<0.05),GOLD分期更严重(I期27.0%对39.4%,II期50.2%对46.8%,III期17.0%对11.1%,IV期5.8%对2.7%,P<0.05),肺功能指标更差(FEV、FVC、PEF、FEF、FEF、FEF、FEF)(P<0.05)。

结论

发现COPD在苏州40岁及以上成年人中高度流行。年龄和体重过轻是COPD的主要危险因素。一半的COPD患者无症状,且在出现呼吸道症状时肺功能下降。因此,肺量计筛查对于COPD的早期检测和管理至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc00/7656423/4d528c544b0c/jtd-12-10-5347-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc00/7656423/8072a2908643/jtd-12-10-5347-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc00/7656423/a15428448b71/jtd-12-10-5347-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc00/7656423/4d528c544b0c/jtd-12-10-5347-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc00/7656423/8072a2908643/jtd-12-10-5347-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc00/7656423/a15428448b71/jtd-12-10-5347-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc00/7656423/4d528c544b0c/jtd-12-10-5347-f3.jpg

相似文献

1
Epidemiology and risk factors of chronic obstructive pulmonary disease in Suzhou: a population-based cross-sectional study.苏州慢性阻塞性肺疾病的流行病学及危险因素:一项基于人群的横断面研究。
J Thorac Dis. 2020 Oct;12(10):5347-5356. doi: 10.21037/jtd-20-1616.
2
Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study.中国慢性阻塞性肺疾病患病率及危险因素研究(CPH 研究):一项全国性横断面研究。
Lancet. 2018 Apr 28;391(10131):1706-1717. doi: 10.1016/S0140-6736(18)30841-9. Epub 2018 Apr 9.
3
The prevalence of chronic obstructive pulmonary disease in Riyadh, Saudi Arabia: a BOLD study.沙特阿拉伯利雅得慢性阻塞性肺疾病的患病率:一项BOLD研究。
Int J Tuberc Lung Dis. 2015 Oct;19(10):1252-7. doi: 10.5588/ijtld.14.0939.
4
Chronic obstructive pulmonary disease prevalence in Lisbon, Portugal: the burden of obstructive lung disease study.葡萄牙里斯本慢性阻塞性肺疾病患病率:阻塞性肺病负担研究
Rev Port Pneumol. 2013 May-Jun;19(3):96-105. doi: 10.1016/j.rppneu.2012.11.004. Epub 2013 May 8.
5
Control of chronic obstructive pulmonary disease in urban populations: findings from a cross-sectional prevalence survey in Shenzhen, China.中国深圳一项横断面患病率调查对城市人口慢性阻塞性肺疾病的控制情况
Environ Sci Pollut Res Int. 2022 Feb;29(8):11843-11853. doi: 10.1007/s11356-021-16553-z. Epub 2021 Sep 22.
6
2017 Global Initiative for Chronic Obstructive Lung Disease reclassifies half of COPD subjects to lower risk group.2017年慢性阻塞性肺疾病全球倡议将一半的慢性阻塞性肺疾病患者重新分类到低风险组。
Int J Chron Obstruct Pulmon Dis. 2018 Jan 3;13:165-173. doi: 10.2147/COPD.S151016. eCollection 2018.
7
Estimating prevalence of chronic obstructive pulmonary disease in the Southern Cone of Latin America: how different spirometric criteria may affect disease burden and health policies.估算拉丁美洲南部锥体地区慢性阻塞性肺疾病的流行情况:不同的肺量计标准如何影响疾病负担和卫生政策。
BMC Pulm Med. 2017 Dec 11;17(1):187. doi: 10.1186/s12890-017-0537-9.
8
Gender and chronic obstructive pulmonary disease in high-risk smokers.高危吸烟者中的性别与慢性阻塞性肺疾病
Respiration. 2006;73(3):306-10. doi: 10.1159/000090051. Epub 2005 Nov 29.
9
10
Newly diagnosed chronic obstructive pulmonary disease. Clinical features and distribution of the novel stages of the Global Initiative for Obstructive Lung Disease.新诊断的慢性阻塞性肺疾病。慢性阻塞性肺疾病全球倡议新分期的临床特征及分布情况
Respiration. 2003 Jan-Feb;70(1):67-75. doi: 10.1159/000068417.

引用本文的文献

1
Association of single-nucleotide polymorphism with spirometry indices and pulmonary ventilation characteristics in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者单核苷酸多态性与肺量计指标及肺通气特征的关联
J Int Med Res. 2025 Sep;53(9):3000605251372069. doi: 10.1177/03000605251372069. Epub 2025 Sep 2.
2
Relationship Between Phenotypical and Echocardiographic Findings With Pulmonary Hypertension in COPD Patients.慢性阻塞性肺疾病(COPD)患者的表型与超声心动图检查结果和肺动脉高压之间的关系
Pulm Circ. 2025 Aug 16;15(3):e70153. doi: 10.1002/pul2.70153. eCollection 2025 Jul.
3
Age-Related Variations and Seasonal Influences: A Network Analysis of Comorbidities in Asthma Hospitalizations (2013-2023).

本文引用的文献

1
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家层面 195 个国家和地区 1990 年至 2017 年 354 种疾病和伤害导致的发病率、患病率和伤残损失寿命年:基于 2017 年全球疾病负担研究的系统分析。
Lancet. 2018 Nov 10;392(10159):1789-1858. doi: 10.1016/S0140-6736(18)32279-7. Epub 2018 Nov 8.
2
Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、地区和国家残疾调整生命年(DALYs)359 种疾病和伤害以及 195 个国家和地区 1990-2017 年的健康期望寿命(HALE):2017 年全球疾病负担研究的系统分析。
Lancet. 2018 Nov 10;392(10159):1859-1922. doi: 10.1016/S0140-6736(18)32335-3.
3
年龄相关差异和季节影响:2013 - 2023年哮喘住院合并症的网络分析
J Clin Med. 2025 Mar 29;14(7):2350. doi: 10.3390/jcm14072350.
4
Prevalence and clinical correlates of chronic obstructive pulmonary disease in heart failure patients: a cross-sectional study in China.心力衰竭患者中慢性阻塞性肺疾病的患病率及临床相关性:一项中国的横断面研究
Front Med (Lausanne). 2025 Feb 3;12:1477388. doi: 10.3389/fmed.2025.1477388. eCollection 2025.
5
Prevalence of non-smoking chronic obstructive pulmonary disease and its risk factors in China: a systematic review and meta-analysis.中国非吸烟慢性阻塞性肺疾病的患病率及其危险因素:系统评价和荟萃分析。
BMC Public Health. 2024 Oct 30;24(1):3010. doi: 10.1186/s12889-024-20170-z.
6
Estimating the global prevalence of chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis.估算慢性阻塞性肺疾病(COPD)的全球患病率:一项系统评价与荟萃分析
BMC Public Health. 2024 Jan 25;24(1):297. doi: 10.1186/s12889-024-17686-9.
7
Prevalence and Risk Factors for COPD in an Urbanizing Rural Area in Western China: A Cross-Sectional Study.中国西部农村城市化地区 COPD 的患病率及其危险因素:一项横断面研究。
Int J Chron Obstruct Pulmon Dis. 2023 Apr 4;18:459-468. doi: 10.2147/COPD.S400213. eCollection 2023.
8
Epidemiological evidence relating risk factors to chronic obstructive pulmonary disease in China: A systematic review and meta-analysis.中国与慢性阻塞性肺疾病相关危险因素的流行病学证据:系统评价和荟萃分析。
PLoS One. 2021 Dec 28;16(12):e0261692. doi: 10.1371/journal.pone.0261692. eCollection 2021.
Disease burden of COPD in China: a systematic review.中国慢性阻塞性肺疾病的疾病负担:一项系统评价。
Int J Chron Obstruct Pulmon Dis. 2018 Apr 27;13:1353-1364. doi: 10.2147/COPD.S161555. eCollection 2018.
4
Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study.中国慢性阻塞性肺疾病患病率及危险因素研究(CPH 研究):一项全国性横断面研究。
Lancet. 2018 Apr 28;391(10131):1706-1717. doi: 10.1016/S0140-6736(18)30841-9. Epub 2018 Apr 9.
5
Chronic obstructive pulmonary disease associated with biomass fuel use in women: a systematic review and meta-analysis.女性生物质燃料使用相关的慢性阻塞性肺疾病:一项系统评价和荟萃分析。
BMJ Open Respir Res. 2018 Jan 12;5(1):e000246. doi: 10.1136/bmjresp-2017-000246. eCollection 2018.
6
Tiotropium in Early-Stage Chronic Obstructive Pulmonary Disease.噻托溴铵治疗早期慢性阻塞性肺疾病。
N Engl J Med. 2017 Sep 7;377(10):923-935. doi: 10.1056/NEJMoa1700228.
7
Prognosis of asymptomatic and symptomatic, undiagnosed COPD in the general population in Denmark: a prospective cohort study.丹麦一般人群中无症状和有症状、未经诊断的 COPD 的预后:一项前瞻性队列研究。
Lancet Respir Med. 2017 May;5(5):426-434. doi: 10.1016/S2213-2600(17)30119-4. Epub 2017 Apr 4.
8
Prevalence of Small-Airway Dysfunction among COPD Patients with Different GOLD Stages and Its Role in the Impact of Disease.不同GOLD分级的慢性阻塞性肺疾病患者小气道功能障碍的患病率及其在疾病影响中的作用
Respiration. 2017;93(1):32-41. doi: 10.1159/000452479. Epub 2016 Nov 17.
9
Asymptomatic subjects with airway obstruction have significant impairment at exercise.无症状气道阻塞患者在运动时会出现明显的功能损害。
Thorax. 2016 Sep;71(9):804-11. doi: 10.1136/thoraxjnl-2015-207953. Epub 2016 May 25.
10
Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function.肺功能正常的吸烟者症状的临床意义
N Engl J Med. 2016 May 12;374(19):1811-21. doi: 10.1056/NEJMoa1505971.